6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(4-hydroxyphenyl)-1H-3-benzazepinium bromide

6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(4-hydroxyphenyl)-1H-3-benzazepinium bromide Structure
CAS No.
67287-54-1
Chemical Name:
6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(4-hydroxyphenyl)-1H-3-benzazepinium bromide
Synonyms
SKF 82526 HydrobroMide;FenoldopaM HydrobroMide;(±)-SKF 82526 HydrobroMide;FENOLDOPAM MONOHYDROBROMIDE;Fenoldopam Monohydrobromide DISCONTINUED, offer F248790;6-Chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1H-3-benzazepine-7,8-diol HydrobroMide;6-Chloro-1-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-benzo[d]azepine-7,8-diol hydrobromide;6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(4-hydroxyphenyl)-1H-3-benzazepinium bromide;6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1h-3-benzazepine-7,8-diol monohydrobromide
CBNumber:
CB3880764
Molecular Formula:
C16H16ClNO3.BrH
Molecular Weight:
386.67
MOL File:
67287-54-1.mol
Modify Date:
2023/4/23 13:52:06

6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(4-hydroxyphenyl)-1H-3-benzazepinium bromide Properties

Melting point >233°C (dec.)
storage temp. 2-8°C
solubility DMSO: >12mg/mL
form Solid
color off-white

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07,GHS08
Signal word  Danger
Hazard statements  H302-H317-H319-H334
Precautionary statements  P261-P280-P305+P351+P338-P342+P311
Hazard Codes  Xn
Risk Statements  22-36-42/43
Safety Statements  22-26-36/37/39
WGK Germany  3

6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(4-hydroxyphenyl)-1H-3-benzazepinium bromide Chemical Properties,Uses,Production

Uses

Dopamine D1-receptor agonist. Antihypertensive.

Biochem/physiol Actions

Fenoldopam is a selective dopamine agonist that is being considered for the parenteral treatment of systemic hypertension. In both an oral and parenteral form, fenoldopam causes peripheral vasodilation by stimulating dopamine-1 adrenergic receptors. Intravenous fenoldopam may provide advantages over sodium nitroprusside because it can induce both a diuresis and natriuresis, is not light sensitive, and is not associated with cyanide toxicity. There is no evidence for rebound hypertension after discontinuation of fenoldopam infusion.

6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(4-hydroxyphenyl)-1H-3-benzazepinium bromide Preparation Products And Raw materials

Raw materials

Preparation Products

6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(4-hydroxyphenyl)-1H-3-benzazepinium bromide Suppliers

Global( 22)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Pharma Affiliates 172-5066494 Haryana, India 6761 58 Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
Pharmaffiliates Analytics and Synthetics P. Ltd +91-172-5066494 Haryana, India 6773 58 Inquiry
LEAP CHEM CO., LTD. +86-852-30606658 China 24738 58 Inquiry
Shanghai EFE Biological Technology Co., Ltd. 021-65675885 18964387627 China 9708 58 Inquiry
Guangzhou Isun Pharmaceutical Co., Ltd 020-39119399 18927568969 China 4428 55 Inquiry
Hangzhou Bingochem Co., Ltd. 0571-87632989 China 21673 58 Inquiry
Shanghai Haohong Scientific Co., Ltd. 400-400-8210725 China 40041 58 Inquiry
TargetMol Chemicals Inc. 15002134094 China 28118 58 Inquiry
SIGMA-RBI 800 736 3690 (Orders) Switzerland 6913 91 Inquiry

67287-54-1(6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(4-hydroxyphenyl)-1H-3-benzazepinium bromide)Related Search:

(±)-SKF 82526 HydrobroMide 6-Chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1H-3-benzazepine-7,8-diol HydrobroMide SKF 82526 HydrobroMide 6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(4-hydroxyphenyl)-1H-3-benzazepinium bromide FENOLDOPAM MONOHYDROBROMIDE 6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1h-3-benzazepine-7,8-diol monohydrobromide FenoldopaM HydrobroMide Fenoldopam Monohydrobromide DISCONTINUED, offer F248790 6-Chloro-1-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-benzo[d]azepine-7,8-diol hydrobromide 67287-54-1 C16H16ClNO3HBr C16H17BrClNO3 BrHC16H16ClNO3 Agonists Aromatics Heterocycles Intermediates & Fine Chemicals Neurochemicals Pharmaceuticals